Rare
lephants
Screener
Toggle theme
ENANTA PHARMACEUTICALS, INC
ENTA
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Total Cash from Operations:
$22.6M
Line Item
Value
% of Total
Capital Expenditures
$252.0K
1.1%
Other Investing
$17.8M
78.6%
Other Financing
$909.0K
4.0%
Net Cash Flow
$3.7M
16.2%
